Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 17, 2018Case Reports in Oncological MedicineOpen Access

A Rare Case of Pembrolizumab-Induced Reactivation of Hepatitis B

View Full Paper
Ask AI
Bookmark
Share

Authors

APAnita PandeySwami Vivekanand Subharti UniversitySESusan EzemenariMLMaksim Liaukovich

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pandey et al. (2018) studied this question.

synapsesocial.com/papers/6aaf8eafc5a6748b3a7771c5https://doi.org/10.1155/2018/5985131
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy2004 · 313 citations
  2. 2The metabolic regulator PGC‐1α links anti‐cancer cytotoxic chemotherapy to reactivation of hepatitis B virus2012 · 11 citations
  3. 3Hepatitis B virus reactivation and alemtuzumab therapy2005 · 123 citations
  4. 4Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity2012 · 1,873 citations
  5. 5Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC.2017 · 126 citations